Form 8-K AQUINOX PHARMACEUTICALS, For: Oct 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Aquinox Pharma (AQXP) Will Review Full LEADERSHIP Trial Data at R&D Day
October 7, 2015 9:20 AM EDTOn October 7, 2015, Aquinox Pharma (NASDAQ: AQXP) will host an R&D Day in New York City from 8:30 AM to 10:00 AM Eastern Time. The Company will be reviewing the full data from its recently completed LEADERSHIP trial and provide an update on the clinical... More
